MP26-16 RACIAL AND ECONOMIC DISPARITIES IN THE USE OF NEOADJUVANT CHEMOTHERAPY FOR PATIENTS WITH UROTHELIAL MUSCLE INVASIVE BLADDER CANCER

Authors :: Dennis J. Robins
Viktor X. Flores
Brian K. McNeil
Nicholas R Suss
Andrew G. Winer
Jeffrey P. Weiss
Matthew Smith
Source :: Journal of Urology. 201
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.
Abstract: INTRODUCTION AND OBJECTIVES:Neoadjuvant chemotherapy (NAC) combined with radical cystectomy (RC) and urinary diversion is the standard of care in the treatment of urothelial muscle invasive bladder...

Subjects :: medicine.medical_specialty
Chemotherapy
Bladder cancer
Standard of care
business.industry
Urology
medicine.medical_treatment
Urinary diversion
Muscle invasive
medicine.disease
Cystectomy
medicine
business
human activities

Tools